These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 12746453)
21. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome. Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440 [TBL] [Abstract][Full Text] [Related]
22. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Leng X; Connell-Crowley L; Goodrich D; Harper JW Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720 [TBL] [Abstract][Full Text] [Related]
23. The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Xia X; Cheng A; Akinmade D; Hamburger AW Mol Cell Biol; 2003 Mar; 23(5):1717-25. PubMed ID: 12588990 [TBL] [Abstract][Full Text] [Related]
24. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654 [TBL] [Abstract][Full Text] [Related]
25. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
26. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. Kavurma MM; Khachigian LM J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485 [TBL] [Abstract][Full Text] [Related]
27. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population. Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350 [TBL] [Abstract][Full Text] [Related]
28. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Sawa H; Ohshima TA; Ukita H; Murakami H; Chiba Y; Kamada H; Hara M; Saito I Oncogene; 1998 Apr; 16(13):1701-12. PubMed ID: 9582018 [TBL] [Abstract][Full Text] [Related]
29. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912 [TBL] [Abstract][Full Text] [Related]
30. p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. Alt JR; Gladden AB; Diehl JA J Biol Chem; 2002 Mar; 277(10):8517-23. PubMed ID: 11751903 [TBL] [Abstract][Full Text] [Related]
35. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
36. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b. Meng H; Tian L; Zhou J; Li Z; Jiao X; Li WW; Plomann M; Xu Z; Lisanti MP; Wang C; Pestell RG Cell Cycle; 2011 Jan; 10(1):73-81. PubMed ID: 21200149 [TBL] [Abstract][Full Text] [Related]
37. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Barrera-Hernandez G; Park KS; Dace A; Zhan Q; Cheng SY Endocrinology; 1999 Nov; 140(11):5267-74. PubMed ID: 10537157 [TBL] [Abstract][Full Text] [Related]
38. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway. Whittaker SR; Walton MI; Garrett MD; Workman P Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633 [TBL] [Abstract][Full Text] [Related]
39. Cyclin K and cyclin D1b are oncogenic in myeloma cells. Marsaud V; Tchakarska G; Andrieux G; Liu JM; Dembele D; Jost B; Wdzieczak-Bakala J; Renoir JM; Sola B Mol Cancer; 2010 May; 9():103. PubMed ID: 20459741 [TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. Liu E; Li X; Yan F; Zhao Q; Wu X J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]